Multiparameter phenotypic screening for endogenous TFEB and TFE3 translocation identifies novel chemical series modulating lysosome function.
Carling PJ. et al, (2022), Autophagy, 1 - 14
Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomain.
Szykowska A. et al, (2021), Structure (London, England : 1993), 29, 1241 - 1252.e5
A novel high-content imaging-based technique for measuring binding of Dickkopf-1 to low-density lipoprotein receptor-related protein 6
Priestley RS. et al, (2019), Journal of Pharmacological and Toxicological Methods, 95, 47 - 55
Tackling gaps in developing life‐changing treatments for dementia
Mauricio R. et al, (2019), Alzheimer's & Dementia: Translational Research & Clinical Interventions, 5, 241 - 253
Small vessels, dementia and chronic diseases – molecular mechanisms and pathophysiology
Horsburgh K. et al, (2018), Clinical Science, 132, 851 - 868
A standardized clinical evaluation of phenotypic diversity in diabetic polyneuropathy
Scholz J. et al, (2016), Pain, 157, 2297 - 2308
Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA Parkinsonian model is associated with inhibition of microglial activation and MMP expression
Sadeghian M. et al, (2012), Journal of Neuroimmunology, 246, 69 - 77
Down-regulation of the ATP-binding Cassette Transporter 2 (Abca2) Reduces Amyloid-β Production by Altering Nicastrin Maturation and Intracellular Localization
Michaki V. et al, (2012), Journal of Biological Chemistry, 287, 1100 - 1111
Neuroprotection by the selective iNOS inhibitor GW274150 in a model of Parkinson disease
Broom L. et al, (2011), Free Radical Biology and Medicine, 50, 633 - 640
Xenon reduces activation of transient receptor potential vanilloid type 1 (TRPV1) in rat dorsal root ganglion cells and in human TRPV1-expressing HEK293 cells
White JPM. et al, (2011), Life Sciences, 88, 141 - 149
A Key Role for gp130 Expressed on Peripheral Sensory Nerves in Pathological Pain
Andratsch M. et al, (2009), Journal of Neuroscience, 29, 13473 - 13483
The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission
Lambert GA. et al, (2009), Naunyn-Schmiedeberg's Archives of Pharmacology, 380, 311 - 325
Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson’s disease
Marinova-Mutafchieva L. et al, (2009), Journal of Neurochemistry, 110, 966 - 975
Autoradiographical imaging of PPARγ agonist effects on PBR/TSPO binding in TASTPM mice
Roberts JC. et al, (2009), Experimental Neurology, 216, 459 - 470
Endogenous Tumor Necrosis Factor (TNF ) Requires TNF Receptor Type 2 to Generate Heat Hyperalgesia in a Mouse Cancer Model
Constantin CE. et al, (2008), Journal of Neuroscience, 28, 5072 - 5081
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasma
Cutler P. et al, (2008), PROTEOMICS – CLINICAL APPLICATIONS, 2, 467 - 477
The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer's disease patients responding to treatment with rosiglitazone
Akuffo EL. et al, (2008), Biomarkers, 13, 618 - 636
Characterization of SB-705498, a Potent and Selective Vanilloid Receptor-1 (VR1/TRPV1) Antagonist That Inhibits the Capsaicin-, Acid-, and Heat-Mediated Activation of the Receptor
Gunthorpe MJ. et al, (2007), Journal of Pharmacology and Experimental Therapeutics, 321, 1183 - 1192